1SallustoT, Lanzavecchia, A, Mackay CR. Chemokines and chemokine receptors in T-cell priming and Th1/Th2-mediated responses [J]. Immun Today, 1998, 19(12): 568-574.
2Imai T, Hieshima K, Haskell C, et al. Identification and molecular characterization of fractalkine receptor CX3CR1, which medieates both leukocyte migration and adhesion [J]. Cell, 1997, 91(4): 521-530.
3Qin S, Rottman JB, Myers P, et al. The chemokine receptors CXCR3 and CCR5 mark subset of T cells associated with certain inflammatory reaction[J]. J Clin. Invest, 1998, 101(4): 746-754.
4Bonecchi R, Bianchi G, Bordignon P, et al. Deferential expression of chemokine receptors and chemotactic responsiveness in TH1 and TH2 cells[J]. J Exp Med, 1998, 187(1): 127-135.
5Loetscher P, Uguccioni MG, Bordoli J, et al. CCR5 is characteristic of TH1 lymphocytes [J]. Nature, 1998, 391(6665): 344-345.
6Annunziato F, Cosmi L, Galli G, et al. Assessment of chemokine receptor expression by human TH1, TH2 cells in vitro and vivo [J]. J Leuko Bio, 1999, 65(3): 691-699.
7Kawai T, Soki M, Hiromatsu K, et al. Selective Diapedesis of TH1 cells induced by endothelial cell RANTES [J]. J Immun, 1999, 163(6): 3269-3278.
8Bruce K, Czerniewski PM, Andersson J, et al. Regulation of CCR5 and CXCR4 expression by Type 1 and Type 2 cytokines: CCR5 expression is downregulated by IL-10 in CD4-positive lymphocytes [J]. Clin Immune, 1997, 91(1): 254-262.
9Sallusto F, Mackay CR, Lanzavecchia A. Selective expression of eotaxin receptor CCR3 by human T helper 2 cells [J]. Science, 1997, 277(5334): 2005-2007.
10Lioyd CM, Delaney T, Nguyen T, et al. CC chemoking receptor (CCR3)/Eotaxin is followed by CCR4/Monocyte-derived chemokine in medicating pulmonary T helper lymphocyte Type2 recruitment after serial antigen challenge in vivo [J]. J Exp Med, 2000, 196(1): 265-273.